5 , A16A17 (2021)
Study Results: 60% faster wound closure rates Increased blood vessel density Enhanced collagen type I synthesis Improved tensile strength of healed tissue Gastrointestinal Research Findings Research published in World Journal of Gastroenterology demonstrated BPC-157s protective effects in various GI research models, showing significant gastroprotective activity, reduced inflammatory marker expression, enhanced mucosal blood flow, and accelerated ulcer healing rates
Yes, people with type 2 diabetes can develop serious conditions causing severe stomach pain that require urgent medical attention, including diabetic ketoacidosis (especially if taking SGLT2 inhibitors), acute pancreatitis (particularly with GLP-1 receptor agonists), and gallbladder disease
CahillLChiuveSMekaryRJensenMFlintAHuFet alProspective study of breakfast eating and incident coronary heart disease in a cohort of male US health professionals
Tax cuts that wouldn't be offset in any meaningful way by spending cuts
Table 1: Initial use restrictions for Wegovy by commercial plans Source: Clarivate Fingertip Restrictions and payers respective prior authorization documents In addition to a relatively light hand in restricting access, Aetna, Cigna, and Anthem list Wegovy on Tier 2 of their commercial and employer formularies, reflecting widespread coverage for the drug (Fingertip Analytics, accessed February 2024)
